Results 171 to 180 of about 45,683 (251)

Opioid overdose mortality among black people receiving a community- & theory-based multilevel opioid overdose intervention in Indianapolis, U.S.A., 2022-2025. [PDF]

Prev Med Rep
Seo DC, Im D, Satterfield N, Agley J, Williamson F, Crabtree C.   +5 more
europepmc   +1 more source

Targeting Mu Opioid Receptor Neurons of the Habenula to Limit Naloxone Aversion. [PDF]

Biol Psychiatry
Ozdemir D, Ebner C, Meyer J, Pons F, Champagnol-Di Liberti C, Guimaraes-Olmo I, Rahman MT, Decker AM, Wendling O, Schwartz E, Dumas S, Ehrlich AT, Laverny G, Diana MA, Jin C, Kieffer BL, Darcq E.   +16 more
europepmc   +1 more source

Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs. [PDF]

Curr Pain Headache Rep
Maxwell MK, Anwar AI, Hasoon J, Kaye AD.
europepmc   +1 more source

Partially countering the physiological effects of fentanyl with naloxone or d-cysteine ethyl ester in adult goats. [PDF]

J Appl Physiol (1985)
Taylor R, Neumueller SE, DeSalvo J, Hilbert G, Bederman IR, Lewis SJ, Pan LG, Forster HV, Hodges MR.   +8 more
europepmc   +1 more source

Induction de buprénorphine dans l’usage du fentanyl: Stratégies pratiques à l’intention des médecins de famille. [PDF]

Can Fam Physician
Aboud H, Albert OM.
europepmc   +1 more source

Association between a citywide ban on syringe distribution and provision of harm reduction services. [PDF]

Drug Alcohol Depend Rep
Padmanabhan P, Christine P, Pytell J, Wagner N, Gibbons J, Charron C, LeMasters K.   +6 more
europepmc   +1 more source

Mapping needles, reducing harm: Findings from a geospatial, community-based needle collection and naloxone training initiative in Saskatchewan, Canada. [PDF]

Harm Reduct J
Pang N, Varghese SM, Reddy VD, Acoose T, Hidlebaugh E, Kwan S, Rowe M, Medeiros P, Shuper PA, Ibáñez-Carrasco F, Grace D, Eaton AD.   +11 more
europepmc   +1 more source

An Institutional Provider Survey Evaluating Access and Implementation of Opioid Use Disorder Treatment in the Intensive Care Unit. [PDF]

J Addict Med
Quaye AN, Richard JM, Craig WY, Scharnetzki E, Wurcel AG.   +4 more
europepmc   +1 more source

Perceptions surrounding intranasal naloxone use and access among a population experiencing homelessness. [PDF]

Explor Res Clin Soc Pharm
Maurer J, Connor S, Ndung'u M, Solosky B, Okwamba J, Huynh L, Abbott J, Foo I, White AM, Leon-Jhong A, Hurwitz M.   +10 more
europepmc   +1 more source